Regulatory Approval and Compliance Risks: Angiodynamics operates in a highly regulated industry, and failure to obtain or maintain necessary approvals (e.g., FDA, CE Mark) or comply with extensive regulations could halt product sales, lead to recalls, fines, or require significant expenditures.

Product Liability and Safety Risks: The company's medical devices carry inherent risks of adverse events, injury, or death. Product defects, manufacturing errors, or unforeseen side effects could lead to product recalls, litigation, significant damages, reputational harm, and increased insurance costs.

Intense Competition Risks: Angiodynamics faces significant competition from larger, more established companies and innovative startups. Competitors may have greater financial resources, more extensive sales and marketing capabilities, or develop superior or less expensive products, which could erode market share and profitability.